|
公司基本資料信息
|
P-2805 | H-D-Ile-Phe-Lys-pNA | C27H38N6O5 | 526.64 | 76626-41-0 | H-D-Ile-Phe-Lys-pNA |
P-2806 | Isovaleryl-Phe-Lys-pNA | C26H35N5O5 | 497.56 | 178894-43-4 | Isovaleryl-Phe-Lys-pNA |
P-2807 | MeOSuc-Ala-Phe-Lys-AMC | C33H41N5O8 | 635.72 | 201853-92-1 | MeOSuc-Ala-Phe-Lys-AMC |
P-2808 | Suc-Ala-Phe-Lys-AMC | C32H39N5O8 | 621.69 | 73207-91-7 | Suc-Ala-Phe-Lys-AMC |
P-2809 | Urinary Trypsin Inhibitor Fragment | C40H66N14O9S | 919.12 | 164859-77-2 | H-Arg-Gly-Pro-Cys-Arg-Ala-Phe-Ile-OH |
P-2810 | H-D-Val-Leu-Lys-AMC | C27H41N5O5 | 515.65 | 148168-23-4 | H-D-Val-Leu-Lys-AMC |
P-2811 | H-D-Val-Leu-Lys-pNA | C23H38N6O5 | 478.51 | 62354-43-2 | H-D-Val-Leu-Lys-pNA |
P-2901 | Suc-Ala-Pro-pNA | C18H22N4O7 | 406.4 | 95632-46-5 | Suc-Ala-Pro-pNA |
P-2902 | Suc-Gly-Pro-AMC | C21H23N3O7 | 429.43 | 80049-85-0 | Suc-Gly-Pro-AMC |
P-2903 | Z-Ala-Pro-4MβNA | C27H29N3O5 | 475.54 | 74305-55-8 | Z-Ala-Pro-4MβNA |